» Articles » PMID: 35989229

Pregnancy Imparts Distinct Systemic Adaptive Immune Function

Abstract

Problem: Pregnancy represents a state of systemic immune activation that is primarily driven by alterations in circulating innate immune cells. Recent studies have suggested that cellular adaptive immune components, T cells and B cells, also undergo changes throughout gestation. However, the phenotypes and functions of such adaptive immune cells are poorly understood. Herein, we utilized high-dimensional flow cytometry and functional assays to characterize T-cell and B-cell responses in pregnant and non-pregnant women.

Methods: Peripheral blood mononuclear cells from pregnant (n = 20) and non-pregnant (n = 25) women were used for phenotyping of T-cell and B-cell subsets. T-cell proliferation and B-cell activation were assessed by flow cytometry after in vitro stimulation, and lymphocyte cytotoxicity was evaluated by using a cell-based assay. Statistical comparisons were performed with linear mixed-effects models.

Results: Pregnancy was associated with modestly enhanced basal activation of peripheral CD4 T cells. Both CD4 and CD8 T cells from pregnant women showed increased activation-induced proliferation; yet, a reduced proportion of these cells expressed activation markers compared to non-pregnant women. There were no differences in peripheral lymphocyte cytotoxicity between study groups. A greater proportion of B cells from pregnant women displayed memory-like and activated phenotypes, and such cells exhibited higher activation following stimulation.

Conclusion: Maternal circulating T cells and B cells display distinct responses during pregnancy. The former may reflect the unique capacity of T cells to respond to potential threats without undergoing aberrant activation, thereby preventing systemic inflammatory responses that can lead to adverse perinatal consequences.

Citing Articles

Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in mice.

Flores Malavet V, Dhume K, Satchmei A, Arvelo A, Beaird A, Annamalai S J Clin Invest. 2025; 135(1).

PMID: 39744951 PMC: 11684801. DOI: 10.1172/JCI179230.


Immunophenotyping and Activation Status of Maternal Lymphocytes to Predict Spontaneous Preterm Birth in Women With Threatened Preterm Labor: A Prospective Observational Study.

Wendremaire M, Hadi T, Lopez T, Guy J, Neiers F, Garrido C Am J Reprod Immunol. 2024; 92(6):e70015.

PMID: 39625044 PMC: 11613301. DOI: 10.1111/aji.70015.


Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma.

Gomez-Lopez N, Romero R, Escobar M, Carvajal J, Echavarria M, Albornoz L Commun Med (Lond). 2023; 3(1):48.

PMID: 37016066 PMC: 10071476. DOI: 10.1038/s43856-023-00268-y.


Pregnancy-specific responses to COVID-19 are revealed by high-throughput proteomics of human plasma.

Gomez-Lopez N, Romero R, Escobar M, Carvajal J, Echavarria M, Albornoz L Res Sq. 2022; .

PMID: 36032966 PMC: 9413722. DOI: 10.21203/rs.3.rs-1906806/v1.

References
1.
Boly T, Bermick J . Maternal-fetal tolerance: Not just a uterine affair. J Leukoc Biol. 2022; 111(3):515-517. PMC: 10200273. DOI: 10.1002/JLB.5CE1021-560. View

2.
Garcia-Flores V, Romero R, Xu Y, Theis K, Arenas-Hernandez M, Miller D . Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat Commun. 2022; 13(1):320. PMC: 8766450. DOI: 10.1038/s41467-021-27745-z. View

3.
Rowe J, Ertelt J, Aguilera M, Farrar M, Way S . Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe. 2011; 10(1):54-64. PMC: 3140139. DOI: 10.1016/j.chom.2011.06.005. View

4.
Siklos P, Bartalits L, Ungar L, Hercz P, Garam T . Cytotoxic activity of peripheral mononuclear cells in normal pregnancy. Haematologia (Budap). 1985; 18(4):259-64. View

5.
Labiano S, Melendez-Rodriguez F, Palazon A, Teijeira A, Garasa S, Etxeberria I . CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes. Oncoimmunology. 2017; 6(4):e1283468. PMC: 5414881. DOI: 10.1080/2162402X.2017.1283468. View